Table I.
Baseline Characteristics of Patients With and Without the Metabolic Syndrome (MS)
| Patients With MS | Patients Without MS | P Value | |
|---|---|---|---|
| No. | 231 | 318 | |
| Weight, kg | 83.1±12.1 | 73.2±121 | <.001 |
| BMI, kg/m2 | 30.8±4.0 | 28.3±4.7 | <.001 |
| SBP, mm Hg | 153±22 | 148±22 | .020 |
| DBP, mm Hg | 92±11 | 89±11 | .002 |
| Antihypertensive drugs, No. | 2.1±1 | 1.8±1 | .003 |
| BP control, % | 20.6 | 27.4 | .068 |
| Glycemia, mg/dL | 107.0±11.4 | 98.0±8.6 | <.001 |
| Total cholesterol, mg/dL | 220.0±35.0 | 216.2±36.9 | .228 |
| LDL cholesterol, mg/dL | 146.6±31.2 | 140.8±32.0 | .035 |
| HDL cholesterol, mg/dL | 44.8±11.5 | 56.6±12.6 | <.001 |
| Triglycerides, mg/dL | 146.0±64.9 | 97.3±35.8 | <.001 |
| Serum creatinine, mg/dL | 1.05±0.27 | 0.92±0.24 | <.001 |
| Estimated GFR, mL/min/1.73 m2 | 94.4±31.3 | 89.8±30.7 | .091 |
| Microalbuminuria, mg/24 h | 40.7±92.4 | 22.8±40.7 | .009 |
| Microalbuminuria, % | 42.8 | 29.6 | .010 |
| Smokers, % | 16.2 | 15.8 | .692 |
| Abbreviations: BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; GFR, glomerular filtration rate; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; SBP, systolic blood pressure. | |||